β-N-methylamino-L-alanine induces changes in both GSK3 and TDP-43 in human neuroblastoma.

J Toxicol Sci

Departamento de Bioquímica y Biología Molecular I, Universidad Complutense de Madrid, Spain.

Published: October 2013

β-N-methylamino-L-alanine (L-BMAA) is a neurotoxic amino acid produced by most cyanobacteria, which are extensively distributed in different environments all over the world. L-BMAA has been linked to a variety of neurodegenerative diseases. This work aims to analyze the toxicological action of L-BMAA related to alterations observed in different neurodegenerative illness as Alzheimer disease and amyotrophic lateral sclerosis. Our results demonstrate that neuroblastoma cells treated with L-BMAA show an increase in glycogen synthase kinase 3 β (GSk3β) and induce accumulation of TAR DNA-binding protein 43 (TDP-43) truncated forms (C-terminal fragments), phosphorylated  and high molecular weight forms of TDP-43, that appears frequently in some neurodegenerative diseases.

Download full-text PDF

Source
http://dx.doi.org/10.2131/jts.38.425DOI Listing

Publication Analysis

Top Keywords

neurodegenerative diseases
8
β-n-methylamino-l-alanine induces
4
induces changes
4
changes gsk3
4
gsk3 tdp-43
4
tdp-43 human
4
human neuroblastoma
4
neuroblastoma β-n-methylamino-l-alanine
4
l-bmaa
4
β-n-methylamino-l-alanine l-bmaa
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!